BSE filing, NSE: BAZEL. Summary written from the filing by ALFA Finder's alert engine.
Bazel International Ltd: key numbers
- Share price
- ₹20.40
- Market cap
- ₹20.02 Cr
- Revenue (annual)
- ₹4.41 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 24.5×Sector 19.8×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bazel International Ltd
All →Bazel International Other Announcement
Bazel International Ltd filed its quarterly shareholding pattern as per Regulation 31, reporting the current dematerialization status for a promoter's physical shares.
Bazel International Annual General Meeting
Bazel International Ltd held its 44th AGM on September 30, 2026. Shareholders approved financial statements, director re-appointments, and the implementation of the Bazel ESOP Plan 2026.
Bazel International Management Change
Bazel International Ltd announced the resignation of Independent Director Mr. Kawal Singh. His departure is effective from September 28, 2026.
Bazel International Annual General Meeting
Bazel International Ltd has announced its share transfer book closure from September 24 to September 30, 2026. This closure is for the upcoming Annual General Meeting.
Bazel International Annual Report
Bazel International Ltd. filed its Annual Report for FY 2025-26 and the notice for its 44th Annual General Meeting scheduled for September 30, 2026.
Bazel International Board Meeting Outcome
Bazel International Ltd approved its Annual Report, scheduled the 44th AGM for September 30, 2026, and authorized director appointments, auditor changes, and ESOP/Sweat equity plans.
Other bonus issue announcements
All →Shivalik Bimetal Controls Bonus Issue
Shivalik Bimetal added a bonus share proposal and interim dividend to its 04 November 2026 board agenda. Trading window remains closed until 06 November 2026.
Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.